Insignia Financial (PK) Stock Quote IOOFF - Stock Price, News, Charts, Message Board, Trades

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

1.30

Bid

1.22

Ask

2.31

Volume

0.00 Day's Range 0.00

1.30 52 Week Range 1.77

Market Cap

871.944M

Previous Close

1.30

Open

Last Trade

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

Shares Outstanding

670,726,143

Dividend Yield

PE Ratio

34.86

Earnings Per Share (EPS)

0.08

Revenue

1.94B

Net Profit

51.2M

Sector

Investment Advice

Industry

Investment Advice

Website

www.ioof.com.au

Headquarters

Docklands, Victoria, Aus

Founded

1970

Insignia Financial Ltd (PK) is listed in the Investment Advice sector of the OTCMarkets with ticker IOOFF. The last closing price for Insignia Financial (PK) was $1.30. Over the last year, Insignia Financial (PK) shares have traded in a share price range of $ 1.30 to $ 1.77.

Insignia Financial (PK) currently has 670,726,143 shares outstanding. The market capitalization of Insignia Financial (PK) is $871.94 million. Insignia Financial (PK) has a price to earnings ratio (PE ratio) of 34.86.

FeaturedCannabix Technologies to Deliver Innovative Breath Logix Alcohol Screening Device to Texas, USA

Syros to Report Second Quarter 2024 Financial Results on Wednesday, July 31, 2024

Syros Pharmaceuticals (NASDAQ:SYRS), a biopharmaceutical company committed to advancing new standards of care for the frontline treatment of hematologic malignancies, today announced that it will...

Syros to Host Webcast Event on Higher-Risk Myelodysplastic Syndrome and the Opportunity for Tamibarotene to Become the New Frontline Standard-of-Care for Patients with RARA Gene Overexpression

-- Three medical experts will join members of Syros’ leadership team to provide an overview of HR-MDS patient management, perspectives on the current and future treatment landscape, and the...

Syros Receives Fast Track Designation from the FDA for Tamibarotene for the Treatment of Newly Diagnosed Unfit AML with RARA gene overexpression

Syros Pharmaceuticals (NASDAQ:SYRS), a biopharmaceutical company committed to advancing new standards of care for the frontline treatment of hematologic malignancies, today announced that the...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	-0.47	-26.5536723164	1.77	1.77	1.3	405	1.39794239	CS
156	-1.95	-60	3.25	3.52	1.3	590	2.48280726	CS
260	-2.14	-62.2093023256	3.44	5.45	1.3	1281	3.831084	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
BRDSQBird Global Inc (CE)	$ 0.001 (99,900.00%)	23.38k
COGDFCompass Gold Corporation (PK)	$ 0.0491 (12,175.00%)	3k
ASAPQWaitr Holdings Inc (CE)	$ 0.0001 (9,900.00%)	802
AEGYAlternative Energy Partners Inc (CE)	$ 0.0001 (9,900.00%)	1.13M
FONUFONU2 Inc (PK)	$ 0.0001 (9,900.00%)	350k
AMPEAmpio Pharmaceuticals Inc (CE)	$ 0.000001 (-99.91%)	6.81k
WIRXWireless Xcessories Group Inc (CE)	$ 0.000001 (-99.86%)	200
QBIOQ BioMed Inc (CE)	$ 0.000001 (-99.80%)	2.5k
GLBRGlobal Brokerage Inc (CE)	$ 0.000001 (-99.50%)	520
VIAOYVIA optronics AG (CE)	$ 0.0009 (-99.18%)	1.24k
HMBLHUMBL Inc (PK)	$ 0.00026 (4.00%)	135.19M
HIRUHiru Corporation (PK)	$ 0.0038 (46.15%)	126.45M
DPLSDarkPulse Inc (PK)	$ 0.0008 (-11.11%)	95.28M
AITXArtificial Intelligence Technology Solutions Inc (PK)	$ 0.00406 (-4.47%)	89.86M
UBQUUbiquitech Software Corp (PK)	$ 0.000001 (-99.00%)	75.14M